Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001753926-25-000503
Filing Date
2025-03-27
Accepted
2025-03-27 17:08:42
Documents
63
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K g084720_10k.htm   iXBRL 10-K 1971393
2 EXHIBIT 23.1 g084720_ex23-1.htm EX-23.1 3960
3 EXHIBIT 31.1 g084720_ex31-1.htm EX-31.1 13115
4 EXHIBIT 32.1 g084720_ex32-1.htm EX-32.1 6660
10 GRAPHIC img001.jpg GRAPHIC 39933
11 GRAPHIC img002.jpg GRAPHIC 33895
12 GRAPHIC img003.jpg GRAPHIC 50413
13 GRAPHIC img004.jpg GRAPHIC 48159
  Complete submission text file 0001753926-25-000503.txt   7238043

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE chro-20241231.xsd EX-101.SCH 54191
6 XBRL CALCULATION FILE chro-20241231_cal.xml EX-101.CAL 37505
7 XBRL DEFINITION FILE chro-20241231_def.xml EX-101.DEF 153859
8 XBRL LABEL FILE chro-20241231_lab.xml EX-101.LAB 473838
9 XBRL PRESENTATION FILE chro-20241231_pre.xml EX-101.PRE 306767
66 EXTRACTED XBRL INSTANCE DOCUMENT g084720_10k_htm.xml XML 769214
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Channel Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41964 | Film No.: 25780409
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)